CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
CareDx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$67.08+3.08 (+4.81%)
Close on Oct 19, 2026
- Market cap
- $3.58B
- P/E (TTM)
- 32.4
- Dividend yield
- –
CareDx statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | CareDx | Industry median |
|---|---|---|
| Market Cap | $3.47B | $1.14B |
| Enterprise Value | $3.10B | $1.35B |
| PE Ratio | 32.41 | 22.72 |
| PS Ratio | 7.58 | 1.63 |
| PB Ratio | 8.15 | 3.03 |
| P/TBV Ratio | 9.35 | 4.99 |
| P/OCF Ratio | 37.05 | 15.44 |
Enterprise value
| Measure | CareDx | Industry median |
|---|---|---|
| EV / Sales | 6.76 | 1.78 |
| EV / EBITDA | 25.27 | 14.40 |
| EV / EBIT | 28.64 | 19.04 |
Income (trailing twelve months)
| Measure | CareDx | Industry median |
|---|---|---|
| Revenue | $458.09M | $561.90M |
| Operating Income | $108.14M | -$1.81M |
| Pretax Income | $115.19M | -$572.42K |
| Net Income | $111.01M | -$1.16M |
| EBITDA | $122.54M | -$20.72K |
| EPS (Diluted) | $2.07 | -$0.02 |
Margins
| Measure | CareDx | Industry median |
|---|---|---|
| Operating Margin | 23.6% | -4.45% |
| Pretax Margin | 25.1% | 1.54% |
| Profit Margin | 24.2% | -2.91% |
| EBITDA Margin | 26.8% | 2.41% |
Returns
| Measure | CareDx | Industry median |
|---|---|---|
| Return on Equity (ROE) | 29.5% | 1.84% |
| Return on Assets (ROA) | 22.7% | -3.06% |
| Return on Invested Capital (ROIC) | 107.9% | 2.11% |
| Return on Capital Employed (ROCE) | 24.6% | -0.57% |
Growth
| Measure | CareDx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 34.4% | 6.92% |
| Net Income Growth (YoY) | 90.9% | 19.6% |
| Revenue Growth (3Y CAGR) | 5.68% | 10.9% |
| Revenue Growth (5Y CAGR) | 14.6% | 13.2% |
Balance sheet
| Measure | CareDx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $373.64M | $48.71M |
| Net Cash (Debt) | $373.64M | $205.49K |
| Net Cash Per Share | $7.22 | $0.01 |
| Equity (Book Value) | $425.60M | $235.16M |
| Book Value Per Share | $8.23 | $3.48 |
| Tangible Book Value | $371.07M | $703.69K |
| Working Capital | $335.53M | $30.48M |
Financial position
| Measure | CareDx | Industry median |
|---|---|---|
| Current Ratio | 4.58 | 1.40 |
| Quick Ratio | 4.35 | 1.02 |
Cash flow (trailing twelve months)
| Measure | CareDx | Industry median |
|---|---|---|
| Operating Cash Flow | $93.66M | $3.10M |
Efficiency
| Measure | CareDx | Industry median |
|---|---|---|
| Asset Turnover | 0.94 | 0.87 |
| Revenue Per Employee | $598.81K | $228.48K |
| Profits Per Employee | $145.11K | -$8.65K |
| Employee Count | 765 | 913 |
Dividends and yields
| Measure | CareDx | Industry median |
|---|---|---|
| Earnings Yield | 3.20% | -1.25% |
Shares
| Measure | CareDx | Industry median |
|---|---|---|
| Shares Outstanding | 51,734,200 | 58,282,400 |
| Shares Change (YoY) | -8.94% | 2.68% |
| Shares Change (QoQ) | 0.41% | 0.32% |
| Float | 49,108,600 | 33,780,100 |
| Shares Held by Insiders | 5.08% | 16.4% |
| Shares Held by Institutions | 103.2% | 85.9% |
Taxes
| Measure | CareDx | Industry median |
|---|---|---|
| Income Tax | $4.18M | $697.00K |
| Effective Tax Rate | 3.63% | 23.1% |
Scores
| Measure | CareDx | Industry median |
|---|---|---|
| Graham Number | $19.57 | $19.59 |
| Graham Upside | -70.8% | -47.5% |
| Altman Z-Score | 20.35 | 1.96 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from CareDx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.